Literature DB >> 16702826

Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT).

Jirar A Topouchian1, Mohamed A El Assaad, Ludmila V Orobinskaia, Ramzi N El Feghali, Roland G Asmar.   

Abstract

BACKGROUND: Two electronic devices for self-measurement of blood pressure - a brachial monitor, the Omron M6, and a wrist monitor, the Omron R7 - were evaluated in two separate studies according to the International Protocol of the European Society of Hypertension.
DESIGN: The International Validation Protocol is divided into two phases: the first phase is performed on 15 selected participants (45 pairs of blood pressure measurements); if the device passes this phase, 18 supplementary participants are included (54 pairs of blood pressure measurements) making a total number of 33 participants (99 pairs of blood pressure measurements) on whom the final validation is performed.
METHODS: The same methodology recommended by the European Society of Hypertension protocol was applied for both studies. In each study and for each participant, four blood pressure measurements were taken simultaneously by two trained observers using mercury sphygmomanometers alternately with three measurements taken by the tested device. The difference between the blood pressure value given by the device and that obtained by the two observers (mean of the two observers) was calculated for each measure. The 99 pairs of blood pressure differences were classified into three categories (<or=5, <or=10 and <or=15 mmHg). The number of differences in each category was compared with the number required by the International Protocol. An individual analysis was then done to determine the number of comparisons <or=5 mmHg for each participant. At least 22 of the 33 participants should have two of their three comparisons <or=5 mmHg.
RESULTS: In both studies, the two tested devices passed the first and the second phases of the validation process. The average differences between the device and mercury sphygmomanometer readings were 0.8+/-2.7 and -1.9+/-3.3 mmHg for systolic and diastolic blood pressure, respectively, for the Omron M6 device, and 0.2+/-4.2 and 0.2+/-2.9 mmHg for systolic and diastolic blood pressure, respectively, for the Omron R7 device. For both devices, readings differing by less than 5, 10 and 15 mmHg for systolic and diastolic blood pressure values fulfill the recommendation criteria of the International Protocol as well as the individual analysis.
CONCLUSIONS: The Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT) devices fulfilled the validation recommendations of the International Protocol.

Entities:  

Mesh:

Year:  2006        PMID: 16702826     DOI: 10.1097/01.mbp.0000209078.17246.34

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  42 in total

1.  Dimensions of internal migration and their relationship to blood pressure in South Africa.

Authors:  Chantel F Pheiffer; Stephen T McGarvey; Carren Ginsburg; Mark Collinson; F Xavier Gómez-Olivé; Stephen Tollman; Michael J White
Journal:  J Biosoc Sci       Date:  2019-05-27

2.  Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure.

Authors:  Hisako Ushio; Tomoaki Ishigami; Naomi Araki; Shintaro Minegishi; Koichi Tamura; Yasuko Okano; Kazuaki Uchino; Osamu Tochikubo; Satoshi Umemura
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

3.  Physical activity as a preventive measure against overweight, obesity, infections, allergies and cardiovascular disease risk factors in adolescents: AFINOS Study protocol.

Authors:  Oscar L Veiga; Sonia Gómez-Martínez; David Martínez-Gómez; Ariel Villagra; María E Calle; Ascensión Marcos
Journal:  BMC Public Health       Date:  2009-12-19       Impact factor: 3.295

4.  Prediction of 24-hour sodium excretion from spot urine samples in South African adults: a comparison of four equations.

Authors:  Karen Charlton; Lisa J Ware; Glory Chidumwa; Marike Cockeran; Aletta E Schutte; Nirmala Naidoo; Paul Kowal
Journal:  J Hum Hypertens       Date:  2019-05-10       Impact factor: 3.012

5.  The role of physical activity and fitness on the metabolic syndrome in adolescents: effect of different scores. The AFINOS Study.

Authors:  D Martínez-Gómez; J C Eisenmann; J M Moya; S Gómez-Martínez; A Marcos; O L Veiga
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

6.  Body mass index, cardiorespiratory fitness and cardiometabolic risk factors in youth from Portugal and Mozambique.

Authors:  F K dos Santos; A Prista; T N Q F Gomes; D Santos; A Damasceno; A Madeira; P T Katzmarzyk; J A R Maia
Journal:  Int J Obes (Lond)       Date:  2015-06-10       Impact factor: 5.095

7.  Superficial femoral artery plaque, the ankle-brachial index, and leg symptoms in peripheral arterial disease: the walking and leg circulation study (WALCS) III.

Authors:  Mary M McDermott; Kiang Liu; James Carr; Michael H Criqui; Lu Tian; Debiao Li; Luigi Ferrucci; Jack M Guralnik; Christopher M Kramer; Chun Yuan; Melina Kibbe; William H Pearce; Jarett Berry; Walter McCarthy; Yihua Liao; Dongxiang Xu; Jennifer Orozco; Timothy J Carroll
Journal:  Circ Cardiovasc Imaging       Date:  2011-03-24       Impact factor: 7.792

8.  Hypertension, diabetes and overweight: looming legacies of the Biafran famine.

Authors:  Martin Hult; Per Tornhammar; Peter Ueda; Charles Chima; Anna-Karin Edstedt Bonamy; Benjamin Ozumba; Mikael Norman
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

9.  Reproducibility of wrist home blood pressure measurement with position sensor and automatic data storage.

Authors:  Sakir Uen; Rolf Fimmers; Miriam Brieger; Georg Nickenig; Thomas Mengden
Journal:  BMC Cardiovasc Disord       Date:  2009-05-27       Impact factor: 2.298

10.  Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study.

Authors:  David Martinez-Gomez; Sonia Gomez-Martinez; M Angeles Puertollano; Esther Nova; Julia Wärnberg; Oscar L Veiga; Amelia Martí; Cristina Campoy; Jesus M Garagorri; Cristina Azcona; M Pilar Vaquero; Carlos Redondo-Figuero; Manuel Delgado; J Alfredo Martínez; Miguel Garcia-Fuentes; Luis A Moreno; Ascension Marcos
Journal:  BMC Public Health       Date:  2009-11-15       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.